Replies to post #190138 on Biotech Values

[marthambles]

MNTA would have to divest Glatopa for such a deal to pass muster

Would it though? MNTA has zero control over how the drug is marketed. Sandoz will be calling the shots. Why would an acquisition by Teva be noncompetitive?